Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
BLIS Technologies Ltd. is a Biotechnology Research brand in Dunedin. It is publicly held, and its site is blis.co.nz. It holds two addresses on record, all in New Zealand. Headcount on record is 32. Its work is tagged probiotics, skincare and biotechnology. It is listed alongside seven similar brands, mostly in Biotechnology.
BLIS Technologies Limited is a developer and manufacturer of innovative probiotic solutions.
Founded on the research of Professor John Tagg (University of Otago, New Zealand) the company was formed in 2000 to develop new bacterial species as probiotics for human health applications.
With advanced probiotic strains with specific health targets, BLIS offer partners a unique proposition. Their oral probiotic strains BLIS K12™ and BLIS M18™ were the first strains for oral health and are renowned for their efficacy and backed by 30 years of research.
| Countries | 1 |
|---|---|
| Primary country | NZ |
All codes: NZ
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
32 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Two addresses on record, New Zealand only. Primary: 81 Glasgow Street, South Dunedin, Dunedin.
None linked to this brand.
Nine tags on the brand's own list, among them probiotics, skincare and biotechnology.
Seven peer profiles on record: Pacific Edge Ltd and BIOTech New Zealand.